Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Severe Coronavirus Disease 2019)”

Showing 20 of 0 results

Large-scale testing (Phase 3)Temporarily pausedNCT04341870
What this trial is testing

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO

Who this might be right for
COVID19SARS-CoV-2 Infection
Assistance Publique - Hôpitaux de Paris 27
Large-scale testing (Phase 3)Study completedNCT04884490
What this trial is testing

The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients

Who this might be right for
COVID-19 Pneumonia
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 94
Not applicableStudy completedNCT04667923
What this trial is testing

Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome

Who this might be right for
Covid19ARDS
I.M. Sechenov First Moscow State Medical University 80
Post-approval studies (Phase 4)UnknownNCT05938140
What this trial is testing

Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease

Who this might be right for
COVID-19Renal Insufficiency, Chronic
Chinese PLA General Hospital 30
Not applicableStudy completedNCT04733625
What this trial is testing

The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection

Who this might be right for
Covid19SARS-CoV Infection
Kasr El Aini Hospital 56
Not applicableStudy completedNCT04503525
What this trial is testing

Nutritional Assessment of Hospitalized Patients With COVID-19

Who this might be right for
SARS-CoVNutrition Disorders
Lille Catholic University 90
Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Testing effectiveness (Phase 2)Active Not RecruitingNCT04488081
What this trial is testing

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Who this might be right for
COVID-19
QuantumLeap Healthcare Collaborative 1,500
Large-scale testing (Phase 3)Study completedNCT04374032
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Infection
Bosnalijek D.D 120
Very early researchWithdrawnNCT04528771
What this trial is testing

S-Nitrosylation Therapy of COVID-19

Who this might be right for
SARS-CoV2 InfectionCovid19
James Reynolds
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Not applicableWithdrawnNCT04456426
What this trial is testing

Characteristics of Patients With COVID-19 in Meta State, Colombia

Who this might be right for
COVIDSARS-CoV 2SARS Pneumonia+2 more
Hospital Departamental de Villavicencio
Not applicableStudy completedNCT05894499
What this trial is testing

Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,309
Testing effectiveness (Phase 2)Study completedNCT04561063
What this trial is testing

COVID-19 Prophylaxis South Africa (COVER HCW)

Who this might be right for
Covid19SARS-CoV Infection
University of Witwatersrand, South Africa 1,950
Not applicableStudy completedNCT05439044
What this trial is testing

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Who this might be right for
Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris 4,235
Testing effectiveness (Phase 2)Study completedNCT04468009
What this trial is testing

Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma

Who this might be right for
SARS-Associated CoronavirusCovid19SARS-CoV Infection
Hospital de Infecciosas Francisco Javier Muniz 134
Testing effectiveness (Phase 2)Study completedNCT04312009
What this trial is testing

Losartan for Patients With COVID-19 Requiring Hospitalization

Who this might be right for
Corona Virus InfectionAcute Respiratory Distress SyndromeSARS-CoV Infection
University of Minnesota 205
Not applicableEnded earlyNCT04361344
What this trial is testing

Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection

Who this might be right for
COVID-19 InfectionEncephalitis
Centre Hospitalier de PAU 2
Testing effectiveness (Phase 2)Temporarily pausedNCT04711863
What this trial is testing

Fluvoxamine for Adults With Mild to Moderate COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Coronavirus InfectionMild to Moderate COVID-19
Asan Medical Center 400
Large-scale testing (Phase 3)UnknownNCT04873414
What this trial is testing

Convalescent Plasma as Adjunct Therapy for COVID-19

Who this might be right for
COVID-19
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia 364
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation